In September 2024, Red River Talc LLC (RRT) filed for Chapter 11 bankruptcy to resolve claims of ovarian and other gynecological cancers linked to Johnson & Johnson (RRT’s parent firm) talcum powder. In such cases, claimants vote on whether to accept or reject the Chapter 11 plan of reorganization.
A Bates White team was engaged to evaluate whether the proposed Trust would compensate qualifying ovarian and gynecological cancer claims at or above historical tort system settlement values and ensure “pay-in-full” treatment. The team also conducted scenario analyses around the voting results, including analyzing the vote across certain sub-populations of claimants.
After a two-week trial, Judge Christopher M. Lopez dismissed the case.
Partners Drew Evans and Charlie Mullin submitted reports and provided deposition and trial testimony. Mr. Evans testified on various voting-related scenarios, including whether they meet the bankruptcy code’s threshold for confirmation; Dr. Mullin testified regarding his assessment of whether the Trust would provide similar treatment to pending and future talc claims.
Mr. Evans and Dr. Mullin were supported by a team including Peter Cumbo, Taylor Duncan, Scott Lobel, Katie Luker, Alex Moon, Mariana Odio-Zuñiga, Sarah Peters, Samantha Stewart, and Jinwen Wang.
The team
Partner
Partner
Principal
Chair, Partner
Principal
The team also includes
- Senior Consultant
- Manager
- Manager
- Senior Consultant
- Manager
- Senior Consultant
- Manager
- Senior Consultant
- Manager
- Senior Consultant
- Manager
